2025 H2 -tulosraportti
55 päivää sitten
‧38 min
Tarjoustasot
Oslo Børs
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 475 | - | - | ||
| 368 | - | - | ||
| 423 | - | - | ||
| 325 | - | - | ||
| 22 | - | - |
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 H1 -tulosraportti 28.8. |
| Menneet tapahtumat | ||
|---|---|---|
2025 H2 -tulosraportti 26.2. | ||
2025 Q4 -tulosraportti 26.2. | ||
2025 H1 -tulosraportti 29.8.2025 | ||
2025 Q2 -tulosraportti 29.8.2025 | ||
2024 H2 -tulosraportti 26.2.2025 |
Asiakkaat katsoivat myös
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
·6 t sittenThe technical picture, which I wrote about last week, has so far proven to be "right". It closes a little higher day by day, no big movements, which means it will probably remain stable. My thought is that we are in an accumulation phase, where some are picking up shares at the cheapest price before a potential typical strong rise comes. In my opinion, I believe we will hit the technical price target of 6.1 before too long, as thor continues to deliver exactly what they say. Anyway, one cannot know what thor will do, as it is a rather unpredictable stock, but there is nothing to suggest it deserves a sharp decline.
·4 t sittenI think it's holding up well. The price will come higher in due time. A small piece of news is all it takes. What and when is not so easy to know.- ·8 t sittenAllow myself a small update to those who follow Thor Medical. The company produces alpha-emitting isotopes used in modern cancer treatment: - Targeted treatment (radioligand therapy) - The radiation is sent directly to the cancer cells - Less damage to healthy tissue Technology Thor Medical uses thorium as raw material to extract rare isotopes, among others: - Radium-224 - Lead-212 There is a shortage of such isotopes globally, and they are necessary for new types of cancer treatment. The Fens field is a geological area in Telemark (near Ulefoss in Nome municipality) which has received much attention in recent years due to large deposits of rare metals. The Fens field is a carbonatite complex – a special type of bedrock which is rich in, among other things, - Thorium It is actually one of the most well-known areas in Europe for such resources. The Fens field can therefore become: - An important strategic resource for Europe - A possible basis for new Norwegian mineral industry Thor Medical is directly linked to this area because: - The Fens field contains a lot of thorium - Thor Medical uses thorium to produce medical isotopes - Alf Bjørset's role in both places·7 t sittenEstimates Alpha therapy ( 2 bn USD) But growing extremely fast (20–30%+ annually) This is one of the fastest growing niches in cancer treatment Large pharma companies are investing heavily - Novartis (bought radiopharma companies for billions) - Bayer (Xofigo – radium-based treatment) - AstraZeneca (invests heavily in the field) When "big pharma" enters → the market becomes real Massive shortage of isotopes This is the key: There is not enough raw material in the world today Production is difficult and fragmented Thor Medical solves exactly this! They are: "raw material supplier" to the entire industry Comparison: Pharma = makes the medicine Thor Medical = supplies the "fuel" How big can it get for them? If they succeed: - Becomes one of few global suppliers - Can become market leader, world leader.
- ·9 t sitten · MuokattuGeneral assembly in Thor Medical April 23👌 With each passing day, we are ticking closer towards commercial production, Soon May...
·12 t sitten·12 t sittenThey are lyrical about Thor Medical. "They have been very good at delivering what they are supposed to deliver." "The community really believes in the company " Is some of the refrain…🔥- ·16 t sittenshort seller frantically fighting the upward pressure in the stock..
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2025 H2 -tulosraportti
55 päivää sitten
‧38 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·6 t sittenThe technical picture, which I wrote about last week, has so far proven to be "right". It closes a little higher day by day, no big movements, which means it will probably remain stable. My thought is that we are in an accumulation phase, where some are picking up shares at the cheapest price before a potential typical strong rise comes. In my opinion, I believe we will hit the technical price target of 6.1 before too long, as thor continues to deliver exactly what they say. Anyway, one cannot know what thor will do, as it is a rather unpredictable stock, but there is nothing to suggest it deserves a sharp decline.·4 t sittenI think it's holding up well. The price will come higher in due time. A small piece of news is all it takes. What and when is not so easy to know.
- ·8 t sittenAllow myself a small update to those who follow Thor Medical. The company produces alpha-emitting isotopes used in modern cancer treatment: - Targeted treatment (radioligand therapy) - The radiation is sent directly to the cancer cells - Less damage to healthy tissue Technology Thor Medical uses thorium as raw material to extract rare isotopes, among others: - Radium-224 - Lead-212 There is a shortage of such isotopes globally, and they are necessary for new types of cancer treatment. The Fens field is a geological area in Telemark (near Ulefoss in Nome municipality) which has received much attention in recent years due to large deposits of rare metals. The Fens field is a carbonatite complex – a special type of bedrock which is rich in, among other things, - Thorium It is actually one of the most well-known areas in Europe for such resources. The Fens field can therefore become: - An important strategic resource for Europe - A possible basis for new Norwegian mineral industry Thor Medical is directly linked to this area because: - The Fens field contains a lot of thorium - Thor Medical uses thorium to produce medical isotopes - Alf Bjørset's role in both places·7 t sittenEstimates Alpha therapy ( 2 bn USD) But growing extremely fast (20–30%+ annually) This is one of the fastest growing niches in cancer treatment Large pharma companies are investing heavily - Novartis (bought radiopharma companies for billions) - Bayer (Xofigo – radium-based treatment) - AstraZeneca (invests heavily in the field) When "big pharma" enters → the market becomes real Massive shortage of isotopes This is the key: There is not enough raw material in the world today Production is difficult and fragmented Thor Medical solves exactly this! They are: "raw material supplier" to the entire industry Comparison: Pharma = makes the medicine Thor Medical = supplies the "fuel" How big can it get for them? If they succeed: - Becomes one of few global suppliers - Can become market leader, world leader.
- ·9 t sitten · MuokattuGeneral assembly in Thor Medical April 23👌 With each passing day, we are ticking closer towards commercial production, Soon May...
- ·12 t sitten·12 t sittenThey are lyrical about Thor Medical. "They have been very good at delivering what they are supposed to deliver." "The community really believes in the company " Is some of the refrain…🔥
- ·16 t sittenshort seller frantically fighting the upward pressure in the stock..
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Oslo Børs
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 475 | - | - | ||
| 368 | - | - | ||
| 423 | - | - | ||
| 325 | - | - | ||
| 22 | - | - |
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 H1 -tulosraportti 28.8. |
| Menneet tapahtumat | ||
|---|---|---|
2025 H2 -tulosraportti 26.2. | ||
2025 Q4 -tulosraportti 26.2. | ||
2025 H1 -tulosraportti 29.8.2025 | ||
2025 Q2 -tulosraportti 29.8.2025 | ||
2024 H2 -tulosraportti 26.2.2025 |
2025 H2 -tulosraportti
55 päivää sitten
‧38 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 H1 -tulosraportti 28.8. |
| Menneet tapahtumat | ||
|---|---|---|
2025 H2 -tulosraportti 26.2. | ||
2025 Q4 -tulosraportti 26.2. | ||
2025 H1 -tulosraportti 29.8.2025 | ||
2025 Q2 -tulosraportti 29.8.2025 | ||
2024 H2 -tulosraportti 26.2.2025 |
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·6 t sittenThe technical picture, which I wrote about last week, has so far proven to be "right". It closes a little higher day by day, no big movements, which means it will probably remain stable. My thought is that we are in an accumulation phase, where some are picking up shares at the cheapest price before a potential typical strong rise comes. In my opinion, I believe we will hit the technical price target of 6.1 before too long, as thor continues to deliver exactly what they say. Anyway, one cannot know what thor will do, as it is a rather unpredictable stock, but there is nothing to suggest it deserves a sharp decline.·4 t sittenI think it's holding up well. The price will come higher in due time. A small piece of news is all it takes. What and when is not so easy to know.
- ·8 t sittenAllow myself a small update to those who follow Thor Medical. The company produces alpha-emitting isotopes used in modern cancer treatment: - Targeted treatment (radioligand therapy) - The radiation is sent directly to the cancer cells - Less damage to healthy tissue Technology Thor Medical uses thorium as raw material to extract rare isotopes, among others: - Radium-224 - Lead-212 There is a shortage of such isotopes globally, and they are necessary for new types of cancer treatment. The Fens field is a geological area in Telemark (near Ulefoss in Nome municipality) which has received much attention in recent years due to large deposits of rare metals. The Fens field is a carbonatite complex – a special type of bedrock which is rich in, among other things, - Thorium It is actually one of the most well-known areas in Europe for such resources. The Fens field can therefore become: - An important strategic resource for Europe - A possible basis for new Norwegian mineral industry Thor Medical is directly linked to this area because: - The Fens field contains a lot of thorium - Thor Medical uses thorium to produce medical isotopes - Alf Bjørset's role in both places·7 t sittenEstimates Alpha therapy ( 2 bn USD) But growing extremely fast (20–30%+ annually) This is one of the fastest growing niches in cancer treatment Large pharma companies are investing heavily - Novartis (bought radiopharma companies for billions) - Bayer (Xofigo – radium-based treatment) - AstraZeneca (invests heavily in the field) When "big pharma" enters → the market becomes real Massive shortage of isotopes This is the key: There is not enough raw material in the world today Production is difficult and fragmented Thor Medical solves exactly this! They are: "raw material supplier" to the entire industry Comparison: Pharma = makes the medicine Thor Medical = supplies the "fuel" How big can it get for them? If they succeed: - Becomes one of few global suppliers - Can become market leader, world leader.
- ·9 t sitten · MuokattuGeneral assembly in Thor Medical April 23👌 With each passing day, we are ticking closer towards commercial production, Soon May...
- ·12 t sitten·12 t sittenThey are lyrical about Thor Medical. "They have been very good at delivering what they are supposed to deliver." "The community really believes in the company " Is some of the refrain…🔥
- ·16 t sittenshort seller frantically fighting the upward pressure in the stock..
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Oslo Børs
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 475 | - | - | ||
| 368 | - | - | ||
| 423 | - | - | ||
| 325 | - | - | ||
| 22 | - | - |
Välittäjätilasto
Dataa ei löytynyt